SecBot SecBot

EVOTF

Evotec SE
OTC· Pharmaceutical Preparations· Inc. 2M· CIK 0001412558 Biotech & Drug Discovery
$3.33 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $3.33
1 year
−59.0%
from $8.10 · Oct 28
30 days
−50.3%
from $6.69
52-week range
$3.33–8.10
−59% from high · low Oct 5
Avg volume 20D
5
Oct 5 spike 100
Short interest
3.78M
+34.9%
Days to cover
63.9
at average volume
Filing reports
5
analyzed by SecBot
SecBot read MIXED 5 reports · latest
Balance 1 bearish · 1 bullish · 2 mixed · 1 neutral oldest → newest, height = score
Avg score ·High conf. 5/5
Strongest BEARISH Evotec SE reported Q1 2026 results with a 22% revenue decline to €156.6M and Adjusted EBITDA swinging to…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • Short sellersBUILDING

    Short interest +34.9% to 3.78M shares. 63.9 days to cover.

  • TrendDOWNTREND

    41% below its 50-day average. New closing low $3.33 on Oct 26.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
May 6, 2026 SEC
Evotec SE reported Q1 2026 results with a 22% revenue decline to €156.6M and Adjusted EBITDA swinging to -€21.9M from…
6-K — Impact 6/10
Apr 30, 2026 SEC
Evotec announced the nomination of Dr. Wolfgang Hofmann as an independent Supervisory Board member and entered into a…
6-K — Impact 4/10
Apr 8, 2026 SEC
Evotec reported full-year 2025 results with €788.4 million in revenue, a slight decline from 2024, but a significant…
6-K — Impact 6/10

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$138.7M
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY———$721.4M

Short side

FINRA· Oct 15, 2026
3,780,876
shares short
+34.9%
vs prior settlement
63.9
days to cover

SecBot reports

5 filings · 1 bullish · 1 bearish · 2 mixed · 1 neutral
All EVOTF filing & press-release reports (5)